Abstract
Objectives:
To report current trends in scleral contact lens prescription and management, including lens designs prescribed, care products recommended, and procedures performed during routine scleral lens evaluation.
Methods:
An online survey was designed by the SCOPE (Scleral Lenses in Current Ophthalmic Practice Evaluation) study team and administered to eye care practitioners attending a specialty contact lens meeting. The survey was available from November 8, 2019, through March 31, 2020. Participants’ demographic data were collected, along with information on lens diameters, landing zone designs, recommended care products, and components of routine scleral lens evaluation.
Results:
In total, 715 participants responded to at least 1 of the survey items of interest. Most lenses prescribed (63%) were 16 mm or more in diameter. Lenses with toric landing zones were the most frequently prescribed (48%), followed by spherical (40%), quadrant-specific (8%), and impression- or image-based designs (3%). Most participants (61%) recommended hydrogen peroxide products for lens care. Nonpreserved saline in a single-use vial was most frequently recommended to fill the bowl of the lens before application. Intraocular pressure was measured during scleral lens evaluation by 45% of participants; 38% of participants routinely measured corneal thickness.
Conclusions:
Practitioners increasingly are prescribing scleral lenses with advanced landing zone designs. Most practitioners recommend hydrogen peroxide–based disinfection systems and single-use vials of nonpreserved saline for lens care and application. Because differences in components of routine scleral lens evaluations were reported, clinicians may benefit from reaching a consensus on essential components of scleral lens evaluation.
Keywords: contact lens solutions, corneal thickness, intraocular pressure, landing zone design, scleral lens
An international survey of eye care practitioners was conducted in 2015 by the SCOPE (Scleral Lenses in Current Ophthalmic Practice Evaluation) study team to investigate preferred scleral lens (SL) designs and recommended wearing schedules and lens care regimens.1 Since then, much has changed in SL research and the SL industry. Considerable research has been published about a variety of SL-related topics, such as the effects of SL wear on corneal2, 3 and conjunctival4–6 tissues and on intraocular pressure (IOP).7–9 Additional survey findings suggested that the rate of SL fitting increased from 2015 through 2019.10 Furthermore, a new lens surface treatment and several new SL designs have become available,11–13 and new products have been introduced for the care of SLs.14 Outcomes also have been reported for new SL designs.12, 15, 16 Unfortunately, most reports of outcomes of SL wear originate from academic centers or specialty contact lens practices,17 whereas survey results show that most SL practitioners work outside such institutions.18 Because of this disparity, published research may not accurately represent overall trends in SL prescription and management. Also, continued maturation of the SL industry may have altered SL prescription and management practices. Therefore, updated information about SL prescription and management encompassing all practice types is needed to determine the extent to which research and industry advancements have affected clinical practice.
In 2020, the SCOPE study team conducted a survey-based study similar to the original 2015 investigation. The purpose of this study was to identify interval change for SL prescription and management practices and to assist practitioners in maintaining standards of care consistent with evolving practice patterns within the SL community.
Methods
This study was reviewed and approved by The Ohio State University Institutional Review Board. The research team designed and administered the survey using REDCap (Research Electronic Data Capture)19, 20 tool hosted at The Ohio State University. The survey was introduced at the International Summit of Specialty Contact Lenses on November 8, 2019, and was available until March 31, 2020. A copy of the complete survey is available as supplemental digital content. Also, invitations to complete the survey were emailed to practitioners who had participated in previous surveys and indicated their willingness to be contacted for additional studies, members of the Scleral Lens Education Society, and all attendees at both the International Summit of Specialty Contact Lenses (November 2019, Rome, Italy) and the Global Specialty Lens Symposium (January 2020, Las Vegas, Nevada). Additionally, links to the survey were posted in a private social media group for SL practitioners (Scleral Lens Fitters, Facebook, Meta Platforms Inc) and in 2 online newsletters (I-site and the British Contact Lens Association newsletter).
Data Collection
Only practitioners who had completed 5 or more SL fittings were eligible to complete the survey. Demographic information was collected about the participant’s country of residence and primary type of practice and the year in which the participant began to fit SLs. Participants were asked to estimate the relative percentages of large-diameter (≥16.0-mm) and small-diameter (<16.0-mm) SLs that they prescribed along with the percentages of various landing zone (LZ) designs (spherical, toric, quadrant-specific, or impression- or image-based) that they prescribed in their practices. Participants also were asked to identify the cleaning, disinfecting, and filling solutions they most frequently recommended for their patients and whether they ever recommended the use of tap water with SLs. Finally, participants were asked to identify specific procedures or tests that they routinely performed during follow-up examinations of SL patients. Participants were not required to respond to every item.
Demographic Groups
Descriptive data are reported for all participants. Responses were compared between the various groups of participants (by country of residence, primary practice type, and years of experience fitting SLs). Those reporting the US as their country of residence were compared with all other respondents (“non-US” practitioners). Academic practice was defined as university or academic institutions, hospitals, military, or industry, whereas respondents in private, group, or commercial practice were considered to be in community practice. Practitioners who reported that they began to fit SLs in 2014 or earlier were considered established, whereas those who fit their first SL in 2015 or later were considered new practitioners.
Statistical Analysis
The means and SDs were compared between groups. The lens diameter and LZ designs were compared by using the Mann-Whitney test. Lens solutions recommended were compared with the Pearson χ2 test for association for group comparisons, followed by the Fisher exact test to compare each solution if the group comparison was significant. The yes/no questions about various examination components included in routine SL evaluation were analyzed with χ2 tests, followed by the Fisher exact test for significance. A P value less than .05 was considered significant. Statistical analysis was performed by using Minitab 18 (Minitab LLC).
Results
A total of 922 practitioners responded to the survey. Of these, 8 opened the survey but did not respond to any items, 63 reported fitting fewer than 5 lenses and answered no further questions, 77 had fit more than 5 lenses but chose not to answer any additional questions, and 59 did not respond to any of the items described in this study. The remaining 715 practitioners responded to at least 1 item of interest (lens diameter, LZ design, recommendations for lens care, ancillary testing performed during routine follow-up examination) along with at least 1 item querying demographic information (country of residence, primary practice type, year in which they fit their first SL). Participants’ demographic data are shown in Table 1. Because participants were not required to respond to every item, the number of responses differed for each parameter reported.
Table 1.
Demographic Information for Practitioners Who Responded to the Surveya
| No. (%) | |
|---|---|
| Country of residence (n=713) | |
| US | 450 (63) |
| Non-USb | 263 (37) |
| Primary practice type (n=704) | |
| Community (private, group, commercial practice) | 538 (76) |
| Academic (university, hospital, industry, military, academic institution) | 166 (24) |
| SL-fitting experience (n=705) | |
| Established (first SL fit before 2015) | 474 (67) |
| New (first SL fit in 2015 or later) | 231 (33) |
Abbreviation: SL, scleral lens.
Participants were not required to respond to every survey item; this table includes participants who responded to 1 or more items of interest along with at least 1 item querying demographic information.
Countries represented included the following: Italy (32 participants); Canada (27); India, Spain, and Sweden (14 participants each); United Kingdom (12); Mexico (11); Switzerland (10); France, New Zealand, and South Africa (7 participants each); Columbia, Greece, Netherlands, Norway, and Portugal (6 participants each); Australia and Israel (5 participants each); Brazil, Germany, and Nigeria (4 participants each); Belgium, Denmark, Ecuador, Guatemala, and Saudi Arabia (3 participants each); Algeria, Argentina, China, Costa Rica, Cyprus, Philippines, Poland, Serbia, Taiwan, Trinidad and Tobago, and Uruguay (2 participants each); and Bahrain, Chile, Finland, Iran, Ireland, Japan, Jordan, Kazakhstan, Lebanon, Malaysia, Malta, Morocco, Nepal, Pakistan, Peru, Russian Federation, Singapore, Slovenia, and Venezuela (1 participant each).
Lens Diameter and Design
When asked to estimate the percentages of large-diameter (≥16.0 mm) and small-diameter (<16.0 mm) SLs that they fit, 705 participants responded (Table 2). The mean percentages in each category were calculated. Overall, practitioners reported that 63%±35% (mean±SD) of SLs prescribed had a large diameter, and 37%±34% had a small diameter. US practitioners reported fitting a significantly higher percentage (67%±34%) of lenses 16.0 mm or more in diameter compared with their non-US counterparts (57%±35%) (P=.001), but no significant differences in the percentages of large-diameter and small-diameter SLs were noted between academic and community practitioners or between established and new practitioners.
Table 2.
Distribution of SL Designs Used by Survey Participantsa
| All | US | Non-US | P valueb | Community practice | Academic practice | P valueb | Established SL fitter | New SL fitter | P valueb | |
|---|---|---|---|---|---|---|---|---|---|---|
| Lens diameter, No. (%) of respondents | 705 | 445 (63) | 258 (37) | NA | 532 (77) | 162 (23) | NA | 470 (68) | 225 (32) | NA |
| ≥16 mm | 63±35 | 67±34 | 57±35 | .001 | 62±35 | 68±32 | .07 | 64±34 | 63±36 | 1.0 |
| <16 mm | 37±34 | 33±34 | 43±35 | 38±35 | 32±32 | 36±34 | 37±36 | |||
| Landing zone design, No. (%) of respondents | 665 | 425 (64) | 238 (36) | NA | 495 (76) | 159 (24) | NA | 443 (68) | 212 (32) | NA |
| Spherical | 40±31 | 37±31 | 46±31 | <.001 | 41±32 | 34±29 | .005 | 39±30 | 41±32 | .29 |
| Toric | 48±30 | 50±30 | 44±30 | .01 | 47±30 | 50±29 | .20 | 48±30 | 48±31 | .85 |
| Quadrant-specific | 8±15 | 9±17 | 7±12 | .69 | 7±14 | 12±20 | <.001 | 9±16 | 8±14 | .94 |
| Image- or impression-based | 3±13 | 4±15 | 2±6 | .31 | 3±13 | 3±11 | 18 | 4±14 | 2±8 | .03 |
| Otherc | 1±5 | 1±4 | 1±6 | NA | 1±5 | 1±6 | NA | 1±6 | 1±4 | NA |
Abbreviations: NA, not applicable; SL, scleral lens.
Data are percentage (mean±SD) except where otherwise indicated. Participants were not required to respond to every survey item, so the number of responses differed for each parameter reported. The values in the demographic groups of country of residence, practice type, and experience do not total to the value in the “all” column if participants who responded to the SL design question did not respond to all demographic questions.
Lens diameter and landing zone designs were compared with the Mann-Whitney test.
Participants who indicated that they fit lenses with “other” landing zone designs reported that they design their own lenses but did not specify landing zone designs featured in their lenses.
In total, 665 participants reported the estimated percentages of SLs they fit that featured spherical, toric, quadrant-specific, or image-based or impression-based LZs (Table 2). Overall, participants estimated that 88% of SLs fit had either spherical or toric LZs. Non-US practitioners reported fitting more SLs with spherical LZs than US practitioners, whereas US practitioners reported prescribing SLs with toric LZs more often than non-US practitioners. Academic practitioners reported fitting SLs with quadrant-specific LZs more frequently than community practitioners, whereas community practitioners reported fitting more SLs with spherical LZs than academic practitioners.
Lens Care
Of the participants, 694 responded when asked to identify the disinfection/cleaning system they recommended most frequently for their patients who wear SLs (Table 3). (Participants were asked to identify only their most frequently recommended care products; additional care products that may be recommended were not explored.) Overall, practitioners reported recommending hydrogen peroxide solutions most frequently (61%), with multipurpose solutions for gas-permeable lenses as the next most frequently recommended products (27%). To compare solution use between groups with a χ2 analysis, we removed the “combination” and “other” categories because of low numbers (n=2 for each of these categories). A comparison of the remaining groups found significant differences in the solutions recommended when we compared US vs non-US participants (χ24<.001) and established vs new participants (χ24=.006). US practitioners were more likely to report recommending hydrogen peroxide care products than non-US practitioners, whereas non-US practitioners were more likely than US practitioners to report that they recommend surfactant or alcohol-based cleaners. New practitioners were more likely to report recommending multipurpose solutions and less likely to report recommending surfactant cleaners than their more experienced counterparts. No significant differences were noted between community and academic practitioners (χ24=.67).
Table 3.
Solutions Recommended for SLs by Survey Participants
| All (n=694)a | US (n=438) | Non-US (n=254) | P valueb | Community practice (n=521) | Academic practice (n=162) | P valueb | Established SL fitter (n=461) | New SL fitter (n=223) | P valueb | |
|---|---|---|---|---|---|---|---|---|---|---|
| Lens care products, No. (%) | χ24<.001 | χ24=.67 | χ24=.006 | |||||||
| Hydrogen peroxide solutions | 423 (61) | 306 (70) | 115 (45) | <.001 | 327 (63) | 91 (56) | NA | 280 (61) | 138 (62) | .80 |
| Multipurpose solution for GP lenses | 188 (27) | 108 (24) | 80 (31) | .06 | 136 (26) | 50 (31) | NA | 112 (24) | 72 (32) | .03 |
| Surfactant cleaner | 43 (6) | 14 (3) | 29 (11) | <.001 | 30 (6) | 10 (6) | NA | 37 (8) | 5 (2) | .002 |
| Alcohol-based cleaner | 30 (4) | 7 (2) | 23 (9) | <.001 | 21 (4) | 8 (5) | NA | 24 (5) | 6 (3) | .16 |
| Multipurpose solution for soft lenses | 6 (1) | 3 (1) | 3 (1) | .67 | 5 (1) | 1 (<1) | NA | 5 (1) | 1 (<1) | .67 |
| Combination of productsc | 2 (<1) | 0 (0) | 2 (1) | NA | 1 (<1) | 1 (<1) | NA | 1 (<1) | 1 (<1) | NA |
| Otherc,d | 2 (<1) | 0 (0) | 2 (<1) | NA | 1 (<1) | 1 (1) | NA | 2 (<1) | 0 (0) | NA |
| Fluid used to fill bowl of lens, No. (%) | χ25<.001 | χ25=.33 | χ25=.07 | |||||||
| Preservative-free 0.9% sodium chloride (nebulizer saline) | 284 (41) | 212 (48) | 70 (28) | <.001 | 215 (41) | 65 (40) | NA | 175 (38) | 106 (48) | NA |
| Preservative-free saline for contact lenses in single-use vials | 260 (37) | 146 (33) | 114 (45) | .003 | 192 (37) | 63 (39) | NA | 174 (38) | 81 (36) | NA |
| Preservative-free bottled saline | 118 (17) | 76 (17) | 42 (17) | .83 | 87 (17) | 29 (18) | NA | 87 (19) | 29 (13) | NA |
| Preservative-free artificial tears | 16 (2) | 0 (0) | 16 (6) | <.001 | 11 (2) | 5 (3) | NA | 14 (3) | 2 (1) | NA |
| Multipurpose contact lens solution | 9 (1) | 2 (<1) | 7 (3) | .01c | 9 (2) | 0 (0) | NA | 7 (2) | 2 (1) | NA |
| Bottled saline (preserved) | 7 (1) | 2 (<1) | 5 (2) | .01c | 7 (1) | 0 (0) | NA | 4 (1) | 3 (1) | NA |
| Use of tap water for any aspect of SL care, No. (%) | 40 (6) | 26 (6) | 13 (5) | .73c | 34 (7) | 5 (4) | .25c | 31 (7) | 7 (3) | .05c |
Abbreviations: GP, gas-permeable; NA, not applicable; SL, scleral lens.
The number of participants in the “all” column represents those (of 694 total participants who answered items regarding care products and at least 1 demographic question) who indicated that they recommended various solutions. A total of 692 (438 US+254 non-US) participants answered care product questions in addition to providing their country of origin; 683 participants (521 in community practice+ 162 in academic practice) answered care product questions in addition to providing their type of practice; 684 (461 established SL fitters+223 new SL fitters) answered care product questions in addition to providing their level of expertise.
A χ2 analysis was used to evaluate differences between participant groups. The Fisher exact test was used to calculate P values only if χ2 values were significant; if they were not significant, not applicable is indicated.
Not included in χ2 analysis because of low numbers.
One participant recommended povidone iodine, and 1 participant recommended a protein/lipid remover.
In total, 694 participants reported their most frequently recommended fluid reservoir solution (Table 3). Slightly more practitioners reported recommending off-label use of preservative-free 0.9% sodium chloride solution for nebulizers (41%) than preservative-free saline products designed specifically for contact lenses (37%). Results from a subsequent comparison of groups showed significant differences between US and non-US practitioners (P<.001). Non-US practitioners were more likely to report that they recommended single-use vials of preservative-free saline for contact lenses, preservative-free artificial tears, multipurpose contact lens solutions, or bottled preserved saline. US practitioners, however, were more likely to report that they recommended preservative-free 0.9% sodium chloride (nebulizer saline) (χ25<.001). No significant differences in filling solutions were noted between community and academic practitioners (χ25=.33) or between established and new practitioners (χ25=.07).
Of the 694 participants who responded to the item regarding using tap water with SLs, only 6% reported that they recommended the use of tap water (Table 3). Established practitioners reported that they recommended tap water more frequently than new practitioners.
SL Evaluation Procedures
Nearly half (45%) of all participants reported routinely measuring IOP during SL evaluations (Table 4). Non-US practitioners were more likely to report assessing IOP than US practitioners. Fewer participants (38%) reported regularly measuring corneal thickness in SL wearers. Non-US practitioners were more likely than US practitioners to report assessing corneal thickness.
Table 4.
Components of Routine SL Evaluation Reported by Survey Participantsa
| All | US | Non-US | P value | Community practice | Academic practice | P value | Established SL fitter | New SL fitter | P value | |
|---|---|---|---|---|---|---|---|---|---|---|
| Measure IOP, No./total (%) | 287/641 (45) | 172/411 (42) | 115/228 (50) | .04 | 210/479 (44) | 74/152 (49) | .30 | 190/426 (45) | 93/205 (45) | .86 |
| Measure corneal thickness, No./total (%) | 242/640 (38) | 116/410 (28) | 125/228 (55) | <.001 | 187/479 (39) | 49/151 (33) | .15 | 170/425 (40) | 71/205 (35) | .22 |
| Evaluate for corneal staining after lens removal, No./total (%) | 603/638 (95) | 379/407 (93) | 222/229 (97) | .05 | 449/477 (94) | 144/151 (95) | .69 | 398/425 (94) | 198/203 (98) | .05 |
| Evaluate for conjunctival staining after lens removal, No./total (%) | 584/640 (91) | 374/409 (91) | 208/229 (91) | .77 | 432/477 (91) | 142/153 (93) | .19 | 381/425 (90) | 195/205 (95) | .02 |
| Evert eyelids, No./total (%) | 332/641 (52) | 172/411 (42) | 160/228 (70) | <.001 | 248/478 (52) | 77/153 (50) | .78 | 232/425 (55) | 97/206 (47) | .07 |
| Give dry eye questionnaire, No./total (%) | 137/639 (21) | 80/410 (20) | 57/228 (25) | .11 | 107/477 (22) | 28/152 (18) | .31 | 90/427 (21) | 46/202 (23) | .68 |
| Give visual QOL questionnaire, No./total (%) | 100/636 (16) | 46/410 (11) | 54/224 (24) | <.001 | 78/474 (17) | 20/152 (13) | .20 | 62/421 (15) | 37/205 (18) | .29 |
Abbreviations: IOP, intraocular pressure; QOL, quality of life; SL, scleral lens.
Participants were not required to respond to every survey item, so the number of responses differed for each parameter reported. Analysis was performed by using χ2 with the Fisher exact test.
Overall, most participants reported that they assessed both the cornea (95%) and conjunctiva (91%) for staining with sodium fluorescein after SL removal at each visit, and 52% reported routinely everting the patient’s upper eyelids to evaluate the condition of the superior tarsal conjunctiva (Table 4). Differences in reported rates of corneal evaluation between US and non-US practitioners and between established and new practitioners did not meet the level of significance, but new practitioners were more likely to evaluate for conjunctival staining than established practitioners. Non-US practitioners were more likely to evert the upper eyelids during routine SL evaluation than US practitioners.
Few participants reported administering dry eye or quality of life (QOL) assessments to their SL-wearing patients (Table 4). Of 639 respondents to this item, only 21% reported that they routinely administered a dry eye questionnaire. Even fewer participants reported that they regularly administered a visual QOL questionnaire (16%). Non-US practitioners were more likely to report that they routinely administer QOL questionnaires than their US counterparts.
Discussion
Evidence-based guidelines have not been established yet for optimal SL design characteristics and long-term management of patients wearing SLs. In this discussion, we highlight the changes in practice patterns that have occurred since 2015. This information may allow clinicians to reflect on whether their SL protocols represent the current standard of care for lens design, recommended care products, and examination components of standard SL evaluations.
What Is New in SL Prescribing, Care, and Evaluation
The results from the current study revealed some changes in practitioner-reported SL prescribing and care since the 2015 SCOPE survey. Additionally, the survey provided new data regarding specific LZ designs and components of routine SL evaluation (eg, measuring IOP and corneal thickness).
One of the trends observed is that practitioners now appear to prescribe nonspherical LZ designs more frequently than noted in a study conducted in 2017 describing SL fits in 220 patients (406 eyes).22 In 2015, few laboratories offered lenses with nonspherical LZ designs, and queries regarding the use of various LZ profiles were deemed to be nonrelevant for the 2015 SCOPE survey. Availability of advanced LZ designs just 2 years later led to inclusion of these data in the study conducted in 2017.21 At that time, 64% of lenses prescribed featured spherical LZs vs 26% toric or bitangential LZs.21 In the current study, participants estimated that just 41% of lenses prescribed had spherical LZs, compared with approximately 48% of SLs featuring toric or bitangential LZs.
The types of SL filling solutions that practitioners reported using have changed considerably as well. In 2015, just 62% of participants recommended preservative-free saline in single-use vials; at that time, products specifically designed for use with contact lenses were not available.1 Now the percentage of practitioners who primarily recommend single-use vials of saline has increased to 78% if both nebulizer saline and contact lens–specific products are included. This shift could have been influenced by the following reasons: 1) the discontinuation of a popular nonpreserved bottled saline widely used in 2015 (despite the introduction of a similar product shortly after its discontinuation) and 2) the introduction of single-use, nonpreserved saline products designed specifically for SL use. Fewer practitioners are recommending tap water for the care of SLs; only 6% of participants in this study reported recommending tap water for their patients, compared with 38% of participants in the 2015 study.1 The shift away from recommending preserved saline, nonpreserved saline in multiuse bottles, and tap water in favor of nonpreserved saline delivered in single-use vials is encouraging and may represent an increased appreciation for the effects that fluid in the postlens fluid reservoir might have on the health of corneal epithelial cells.22–25
In 2015, the effects of SL wear on the eyelids, corneal thickness, and IOP were primarily theoretical, and scant peer-reviewed research was available to guide longer-term management. Questions on whether these metrics were evaluated in patients using SLs were not even included in the 2015 SCOPE survey. Since then, several publications have described the interplay between the SL and the cornea2, 26–30 and the SL’s effects on IOP9, 30–34 and the eyelids.35 According to the current study, virtually all practitioners reported routinely assessing for corneal and conjunctival staining after lens removal; however, just over one-third of practitioners reported assessing corneal thickness, almost half reported measuring IOP, and just over half of practitioners reported that they evert the upper eyelids to evaluate the superior tarsal conjunctiva during routine SL evaluation. This finding raises questions as to why routine evaluation of corneal thickness, IOP, and the superior tarsal conjunctiva is not performed regularly by a higher percentage of practitioners. Because most patients who wear SLs do so for the management of ocular disease,18 the relative benefits of their use may outweigh any potential risks of SL-induced glaucomatous optic neuropathy or corneal hypoxia. Recognizing these relative risks and benefits and supported by new research evidence, practitioners may be more carefully monitoring their patients for other indicators of SL-induced complications. If these trends mirror the typical lag between adoption of clinical practice and research, more SL fitters will incorporate these components into their follow-up examinations.
Analysis of published SL-related articles shows that a small number of studies include patient-reported outcomes that could be affected by SL wear.36–39 Research in this area is still in its infancy, and the present study findings suggest that few practitioners routinely use standardized assessment tools to collect outcomes data. Although it would be inaccurate to imply that practitioners are not soliciting patient feedback, low utilization of standardized assessment tools makes it difficult to quantify improvements in patient symptoms or QOL after initiation and continuation of SL wear.
Continuing Practices in SL Prescribing
The new survey results showed little change in the distribution of SL diameters that respondents reported prescribing, compared with 2 previous studies.21, 40 The choice of SL diameter is based on many clinical factors such as aperture width, eyelid tension, and ocular surface pathology. It is not surprising that this feature of lens prescriptions has remained stable.
Regarding LZ designs, quadrant-specific and image-based or impression-based designs are still prescribed infrequently. Large SDs in the distribution of data for both SL diameter and LZ design suggest that considerable differences remain for individual prescribing patterns. These differences may result from the practitioner’s preference or fitting philosophy. Although 42% of participants reported using no quadrant-specific designs, 7 participants (1%) reported using quadrant-specific designs more than 90% of the time. Although 79% of participants reported no use of impression-based or image-based designs, a single participant (<1%) reported prescribing impression-based or image-based designs 90% of the time. Practitioners who have not incorporated more advanced LZ designs into their clinics may achieve adequate results with spherical or toric LZs. The expense for additional equipment and training may also hamper widespread adoption of impression-based or image-based designs, as may the limited number of lens reorders provided by lens manufacturers during the fitting process. The increased cost of more customized lenses may make them a less-desirable option for patients on a limited budget.
Product recommendations for SL disinfection have also changed little since the 2015 survey about SLs. Hydrogen peroxide–based care products continue to be prescribed most frequently; 61% of practitioners reported prescribing these products most frequently in both the 2015 SCOPE survey and the present study. During the COVID-19 pandemic, availability of disinfectants and filling solutions was affected.
Limitations
This study is limited by the constraints present in all survey-based research (eg, potential sampling or response bias) and by participants’ potential inaccuracy of recall or estimation of their actual prescribing practices. When conducting survey-based research, investigators must assume that survey participants accurately report data based on their experience. Although it may be assumed that practitioners accurately reported their experience with aspects of SL fitting investigated in this survey, we could not precisely assess specific prescribing patterns of study participants; nor does the study provide information that would facilitate reasonable speculation about how potential inaccuracies in participants’ estimates may have introduced error into data reported here. However, comparisons between the current and previous study findings lend credence to conclusions regarding SL prescribing and management. Consistency between the results of the 2015 SCOPE survey (based, like the current study, on practitioner recall) and a subsequent study in 2017 (in which participants were asked to provide specific information on a single patient) also suggests that this study design can provide reasonably accurate data.
Conclusion
Based on data reported by study participants, it appears that most SLs being prescribed are at least 16 mm in diameter and that practitioners are increasingly using advanced LZ designs. Study participants report that they most frequently recommend single-use vials of nonpreserved saline to fill the bowl of the SL before application and largely have ceased recommending exposing SLs to tap water. Additionally, most practitioners report measuring clinical metrics of IOP, corneal thickness, and eyelid integrity at follow-up examinations. As best practices within the SL community continue to evolve, it may be helpful to reach a consensus on the essential components of SL evaluation and to regularly administer standardized assessment instruments of patient-reported outcomes, which could more effectively quantify benefits of SL wear.
Supplementary Material
Acknowledgment
Kathleen Louden, ELS, senior scientific/medical editor, Mayo Clinic, substantively edited the manuscript. The Scientific Publications staff, Mayo Clinic, provided proofreading, administrative, and clerical support.
Conflicts of Interest and Source of Funding:
Contamac USA Inc provided an unrestricted grant to the SCOPE Study group to support survey development and distribution. Study design, data collection, data analysis, interpretation of data, writing of the report, and the decision to submit the article for publication were completed by the authors independently.
This publication was supported in part by the National Center for Advancing Translational Sciences of the National Institutes of Health under grant UL1TR002733. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
The study also received support from the National Eye Institute Center Core Grant P30 EY001792hT and from an unrestricted grant from Research to Prevent Blindness.
Declaration of Interest:
Cherie Nau: None
Jennifer Harthan: Consulting for Allergan, Essilor of America, Euclid Systems Corp, International Keratoconus Academy, Metro Optics, Visioneering Technologies Inc, Bausch + Lomb Inc, Kala Pharmaceuticals, Ocular Therapeutix Inc
Ellen Shorter: Research grant from Johnson & Johnson. Consulting: BostonSight
Jennifer Fogt: Research funding from Nevakar Inc, EyeNovia Inc, Alcon, Innovega Inc, Contamac US Inc, Bausch + Lomb. Consulting for Alcon and Contamac US Inc
Amy Nau: Paid lecturer for Eye Eco. Consulting for Oyster Point Pharma Inc
Muriel Schornack: None
Abbreviations
- IOP
intraocular pressure
- LZ
landing zone
- QOL
quality of life
- REDCap
Research Electronic Data Capture
- SCOPE
Scleral Lenses in Current Ophthalmic Practice Evaluation
- SL
scleral lens
Footnotes
Conflict of Interest: The authors have no competing interests to declare.
References
- 1.Harthan J, Nau CB, Barr J, et al. Scleral Lens Prescription and Management Practices: The SCOPE Study. Eye Contact Lens. Sep 2018;44 Suppl 1:S228–S232. doi: 10.1097/ICL.0000000000000387 [DOI] [PubMed] [Google Scholar]
- 2.Fisher D, Collins MJ, Vincent SJ. Fluid reservoir thickness and corneal oedema during closed eye scleral lens wear. Cont Lens Anterior Eye. Feb 2021;44(1):102–107. doi: 10.1016/j.clae.2020.08.002 [DOI] [PubMed] [Google Scholar]
- 3.Fisher D, Collins MJ, Vincent SJ. Anterior segment optical coherence tomography scanning protocols and corneal thickness repeatability. Cont Lens Anterior Eye. Oct 2020;43(5):433–440. doi: 10.1016/j.clae.2019.12.008 [DOI] [PubMed] [Google Scholar]
- 4.Jesus J, Dias L, Almeida I, Costa T, Chibante-Pedro J. Analysis of Conjunctival Vascular Density in Scleral Contact Lens Wearers Using Optical Coherence Tomography Angiography. Cont Lens Anterior Eye. Feb 2022;45(1):101403. doi: 10.1016/j.clae.2020.12.066 [DOI] [PubMed] [Google Scholar]
- 5.Fisher D, Collins MJ, Vincent SJ. Conjunctival prolapse during open eye scleral lens wear. Cont Lens Anterior Eye. Feb 2021;44(1):115–119. doi: 10.1016/j.clae.2020.09.001 [DOI] [PubMed] [Google Scholar]
- 6.Macedo-de-Araujo RJ, Serramito-Blanco M, van der Worp E, Carracedo G, Gonzalez-Meijome JM. Differences between Inferior and Superior Bulbar Conjunctiva Goblet Cells in Scleral Lens Wearers: A Pilot Study. Optom Vis Sci. Sep 2020;97(9):726–731. doi: 10.1097/OPX.0000000000001575 [DOI] [PubMed] [Google Scholar]
- 7.Samaha D, Michaud L. Bruch Membrane Opening Minimum Rim Width Changes During Scleral Lens Wear. Eye Contact Lens. May 1 2021;47(5):295–300. doi: 10.1097/ICL.0000000000000750 [DOI] [PubMed] [Google Scholar]
- 8.Walker MK, Pardon LP, Redfern R, Patel N. IOP and Optic Nerve Head Morphology during Scleral Lens Wear. Optom Vis Sci. Sep 2020;97(9):661–668. doi: 10.1097/OPX.0000000000001567 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Fogt JS, Nau CB, Schornack M, Shorter E, Nau A, Harthan JS. Comparison of Pneumatonometry and Transpalpebral Tonometry Measurements of Intraocular Pressure during Scleral Lens Wear. Optom Vis Sci. Sep 2020;97(9):711–719. doi: 10.1097/OPX.0000000000001574 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Woods CA, Efron N, Morgan P, International Contact Lens Prescribing Survey C. Are eye-care practitioners fitting scleral contact lenses? Clin Exp Optom. Jul 2020;103(4):449–453. doi: 10.1111/cxo.13105 [DOI] [PubMed] [Google Scholar]
- 11.Mickles CV, Harthan JS, Barnett M. Assessment of a Novel Lens Surface Treatment for Scleral Lens Wearers With Dry Eye. Eye Contact Lens. May 1 2021;47(5):308–313. doi: 10.1097/ICL.0000000000000754 [DOI] [PubMed] [Google Scholar]
- 12.Nau A, Shorter ES, Harthan JS, Fogt JS, Nau CB, Schornack M. Multicenter review of impression-based scleral devices. Cont Lens Anterior Eye. Oct 2021;44(5):101380. doi: 10.1016/j.clae.2020.10.010 [DOI] [PubMed] [Google Scholar]
- 13.Nguyen MTB, Thakrar V, Chan CC. EyePrintPRO therapeutic scleral contact lens: indications and outcomes. Can J Ophthalmol. Feb 2018;53(1):66–70. doi: 10.1016/j.jcjo.2017.07.026 [DOI] [PubMed] [Google Scholar]
- 14.Fogt JS, Karres M, Barr JT. Changes in Symptoms of Midday Fogging with a Novel Scleral Contact Lens Filling Solution. Optom Vis Sci. Sep 2020;97(9):690–696. doi: 10.1097/OPX.0000000000001559 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Silverman JIM, Huffman JM, Zimmerman MB, Ling JJ, Greiner MA. Indications for Wear, Visual Outcomes, and Complications of Custom Imprint 3D Scanned Scleral Contact Lens Use. Cornea. May 1 2021;40(5):596–602. doi: 10.1097/ICO.0000000000002588 [DOI] [PubMed] [Google Scholar]
- 16.Barnett M, Carrasquillo KG, Schornack MM. Clinical Outcomes of Scleral Lens Fitting with a Data-driven, Quadrant-specific Design: Multicenter Review. Optom Vis Sci. Sep 2020;97(9):761–765. doi: 10.1097/OPX.0000000000001576 [DOI] [PubMed] [Google Scholar]
- 17.Efron N, Jones LW, Morgan PB, Nichols JJ. Bibliometric analysis of the literature relating to scleral contact lenses. Cont Lens Anterior Eye. Aug 2021;44(4):101447. doi: 10.1016/j.clae.2021.101447 [DOI] [PubMed] [Google Scholar]
- 18.Nau CB, Harthan J, Shorter E, et al. Demographic Characteristics and Prescribing Patterns of Scleral Lens Fitters: The SCOPE Study. Eye Contact Lens. Sep 2018;44 Suppl 1:S265–S272. doi: 10.1097/ICL.0000000000000399 [DOI] [PubMed] [Google Scholar]
- 19.Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. Jul 2019;95:103208. doi: 10.1016/j.jbi.2019.103208 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. Apr 2009;42(2):377–81. doi: 10.1016/j.jbi.2008.08.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Schornack MM, Fogt J, Nau A, et al. Scleral lens prescription and management practices: Emerging consensus. Cont Lens Anterior Eye. Aug 26 2021:101501. doi: 10.1016/j.clae.2021.101501 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Walker MK, Bergmanson JP, Miller WL, Marsack JD, Johnson LA. Complications and fitting challenges associated with scleral contact lenses: A review. Cont Lens Anterior Eye. Apr 2016;39(2):88–96. doi: 10.1016/j.clae.2015.08.003 [DOI] [PubMed] [Google Scholar]
- 23.Walker M, Morrison S, Caroline P, et al. Laboratory Analysis of Scleral Lens Tear Reservoir Clouding. presented at: Global Specialty Lens Symposium; 2014; Las Vegas, NV. [Google Scholar]
- 24.Skidmore KV, Walker MK, Marsack JD, Bergmanson JPG, Miller WL. A measure of tear inflow in habitual scleral lens wearers with and without midday fogging. Cont Lens Anterior Eye. Feb 2019;42(1):36–42. doi: 10.1016/j.clae.2018.10.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Walker MK, Redfern RL, Marsack JD. Protein, Lipid, and Protease Concentrations in the Scleral Lens Tear Film Reservoir. 2016; Anaheim, CA. [Google Scholar]
- 26.Fisher D, Collins MJ, Vincent SJ. Fluid Reservoir Thickness and Corneal Edema during Open-eye Scleral Lens Wear. Optom Vis Sci. Sep 2020;97(9):683–689. doi: 10.1097/OPX.0000000000001558 [DOI] [PubMed] [Google Scholar]
- 27.de Luis Eguileor B, Acera A, Santamaria Carro A, Feijoo Lera R, Escudero Argaluza J, Etxebarria Ecenarro J. Changes in the corneal thickness and limbus after 1 year of scleral contact lens use. Eye (Lond). Sep 2020;34(9):1654–1661. doi: 10.1038/s41433-019-0729-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Vincent SJ, Alonso-Caneiro D, Collins MJ. The time course and nature of corneal oedema during sealed miniscleral contact lens wear. Cont Lens Anterior Eye. Feb 2019;42(1):49–54. doi: 10.1016/j.clae.2018.03.001 [DOI] [PubMed] [Google Scholar]
- 29.Tan B, Tse V, Kim YH, Lin K, Zhou Y, Lin MC. Effects of scleral-lens oxygen transmissibility on corneal thickness: A pilot study. Cont Lens Anterior Eye. Aug 2019;42(4):366–372. doi: 10.1016/j.clae.2019.04.002 [DOI] [PubMed] [Google Scholar]
- 30.Shahnazi KC, Isozaki VL, Chiu GB. Effect of Scleral Lens Wear on Central Corneal Thickness and Intraocular Pressure in Patients With Ocular Surface Disease. Eye Contact Lens. Nov 2020;46(6):341–347. doi: 10.1097/ICL.0000000000000670 [DOI] [PubMed] [Google Scholar]
- 31.Nau CB, Schornack MM, McLaren JW, Sit AJ. Intraocular Pressure After 2 Hours of Small-Diameter Scleral Lens Wear. Eye Contact Lens. Nov 2016;42(6):350–353. doi: 10.1097/ICL.0000000000000214 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Obinwanne CJ, Echendu DC, Agbonlahor O, Dike S. Changes in Scleral Tonometry and Anterior Chamber Angle after Short-term Scleral Lens Wear. Optom Vis Sci. Sep 2020;97(9):720–725. doi: 10.1097/OPX.0000000000001568 [DOI] [PubMed] [Google Scholar]
- 33.Michaud L, Samaha D, Giasson CJ. Intra-ocular pressure variation associated with the wear of scleral lenses of different diameters. Cont Lens Anterior Eye. Feb 2019;42(1):104–110. doi: 10.1016/j.clae.2018.07.004 [DOI] [PubMed] [Google Scholar]
- 34.Kramer EG, Vincent SJ. Intraocular pressure changes in neophyte scleral lens wearers: A prospective study. Cont Lens Anterior Eye. Dec 2020;43(6):609–612. doi: 10.1016/j.clae.2020.05.010 [DOI] [PubMed] [Google Scholar]
- 35.Walker MK, Schornack MM, Vincent SJ. Anatomical and physiological considerations in scleral lens wear: Eyelids and tear film. Cont Lens Anterior Eye. Oct 2021;44(5):101407. doi: 10.1016/j.clae.2021.01.002 [DOI] [PubMed] [Google Scholar]
- 36.Shorter E, Schornack M, Harthan J, et al. Keratoconus Patient Satisfaction and Care Burden with Corneal Gas-permeable and Scleral Lenses. Optom Vis Sci. Sep 2020;97(9):790–796. doi: 10.1097/OPX.0000000000001565 [DOI] [PubMed] [Google Scholar]
- 37.Formisano M, Franzone F, Alisi L, Pistella S, Spadea L. Effects of Scleral Contact Lenses for Keratoconus Management on Visual Quality and Intraocular Pressure. Ther Clin Risk Manag. 2021;17:79–85. doi: 10.2147/TCRM.S293425 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Baudin F, Chemaly A, Arnould L, et al. Quality-of-Life Improvement After Scleral Lens Fitting in Patients With Keratoconus. Eye Contact Lens. Sep 1 2021;47(9):520–525. doi: 10.1097/ICL.0000000000000821 [DOI] [PubMed] [Google Scholar]
- 39.Stason WB, Razavi M, Jacobs DS, et al. Clinical benefits of the Boston Ocular Surface Prosthesis. Am J Ophthalmol. Jan 2010;149(1):54–61. doi: 10.1016/j.ajo.2009.07.037 [DOI] [PubMed] [Google Scholar]
- 40.Harthan J, Shorter E, Nau C, et al. Scleral lens fitting and assessment strategies. Cont Lens Anterior Eye. Feb 2019;42(1):9–14. doi: 10.1016/j.clae.2018.10.020 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
